clinical challenges in the transplant-eligible patient with newly diagnosed multiple myeloma
DESCRIPTION
Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma. Multiple Myeloma Choice of Induction Regimen . Multiple Myeloma Competing Induction Regimens. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/1.jpg)
Clinical Challenges in the Transplant-Eligible Patient With
Newly Diagnosed Multiple Myeloma
![Page 2: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/2.jpg)
![Page 3: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/3.jpg)
![Page 4: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/4.jpg)
![Page 5: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/5.jpg)
![Page 6: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/6.jpg)
![Page 7: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/7.jpg)
![Page 8: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/8.jpg)
![Page 9: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/9.jpg)
Multiple MyelomaChoice of Induction Regimen
![Page 10: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/10.jpg)
![Page 11: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/11.jpg)
![Page 12: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/12.jpg)
Multiple MyelomaCompeting Induction Regimens
![Page 13: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/13.jpg)
![Page 14: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/14.jpg)
Choice of Induction Regimen Use the best drugs early to get maximum remission for as long as possible, both for the standard-risk as well as the high-risk
patients.
![Page 15: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/15.jpg)
Multiple MyelomaEarly vs Delayed HDT/ASCT
![Page 16: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/16.jpg)
Timing of HDT/ASCT Patients with no high-risk disease, who are
responsive and tolerate therapy, may do extremely well with delayed HDT/ASCT.
![Page 17: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/17.jpg)
![Page 18: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/18.jpg)
Multiple MyelomaMaintenance Therapy
![Page 19: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/19.jpg)
![Page 20: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/20.jpg)
Consider No Maintenance For patients with standard-risk disease, stringent CR, normal FLC ratio, who are immunofixation negative in urine and
serum, and have completely negative BM.
![Page 21: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/21.jpg)
Consider Triplet Maintenance For patients with a truly high-risk disease
(eg, stage III myeloma with high-risk cytogenetics).
![Page 22: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/22.jpg)
![Page 23: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/23.jpg)
Abbreviations
![Page 24: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/24.jpg)
Abbreviations (cont)
![Page 25: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/25.jpg)
References
![Page 26: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/26.jpg)
References (cont)
![Page 27: Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma](https://reader036.vdocuments.mx/reader036/viewer/2022062521/568167da550346895ddd37de/html5/thumbnails/27.jpg)
References (cont)